Postmenopausal bleeding: Why women should never ignore bleeding after menopause
Many women dismiss postmenopausal bleeding as just spotting or hormonal variation. But its significance should not be underestimated, because as many as one in three cases is due to a malignancy
Postmenopausal bleeding is a critical health sign that occurs after a year of no menstruation and requires immediate medical evaluation because up to one-third of cases can be linked to malignancies. While many occurrences stem from benign issues like thinning uterine linings or polyps, serious conditions such as endometrial and cervical cancers must be ruled out through diagnostic tools like transvaginal ultrasounds and biopsies
Postmenopausal bleeding is a critical health sign that occurs after a year of no menstruation and requires immediate medical evaluation because up to one-third of cases can be linked to malignancies. While many occurrences stem from benign issues like thinning uterine linings or polyps, serious conditions such as endometrial and cervical cancers must be ruled out through diagnostic tools like transvaginal ultrasounds and biopsies
Postmenopausal bleeding is a critical health sign that occurs after a year of no menstruation and requires immediate medical evaluation because up to one-third of cases can be linked to malignancies. While many occurrences stem from benign issues like thinning uterine linings or polyps, serious conditions such as endometrial and cervical cancers must be ruled out through diagnostic tools like transvaginal ultrasounds and biopsies
Menopause marks the permanent end of menstruation, and with it, a woman’s reproductive life. It occurs when the ovarian follicles stop functioning. This can be confirmed when a woman has not had her periods for 12 consecutive months, with no underlying pathology to explain it.
The final menstrual bleed is, in hindsight, the milestone. Once that milestone has passed, any bleeding from the vagina is called postmenopausal bleeding (PMB). Many women dismiss it as just spotting or hormonal variation. But its significance should not be underestimated, because as many as one in three cases is due to a malignancy.
Not every case is cancer
The commonly seen causes include thinning of the uterine lining (atrophic endometrium), endometrial hyperplasia, and polyps of the uterus or cervix, atrophic vaginitis, etc. The more serious causes are genital cancers, such as cervical cancer and uterine endometrial cancers. Benign and malignant causes can look alike externally; every episode needs proper workup and evaluation. That workup begins in the consulting room.
A detailed history, a general examination, and a per speculum and per vaginal examination together help create a list of possible diagnoses. Pap smear, which is a cervical screening test that detects cancerous changes of the cervix, will also be done as part of the evaluation, which can be later confirmed with colposcopy, direct cervical biopsy, endocervical curettage or conization.
For staging of the tumor, we might need an MRI/ CT / PET CT etc. The first investigation of choice for uterine cancer is usually a transvaginal ultrasound (TVS). If the endometrial thickness is more than 4 mm, further evaluation is a must.
The most widely accepted next step is an office endometrial aspiration biopsy, popularly known as a pipelle biopsy. It is a quick outpatient procedure that samples the endometrium, which is the uterine lining. If the picture remains unclear, other investigations include hysteroscopy, fractional curettage, dilatation and curettage (D&C), or imaging such as CT and MRI. When endometrial cancer is suspected, the most common current treatment protocol involves peritoneal cytology, a hysterectomy with removal of both fallopian tubes and ovaries (bilateral salpingo-oophorectomy), and surgical staging.
Staging tells us how far the disease has spread, and it helps in the decisions that follow. When it comes to early-stage cervical cancer, these can be managed surgically with hysterectomies, whereas locally advanced cancers are treated with radiotherapy /chemotherapy.
What has changed in recent years is how this surgery can be carried out. There are several routes: traditional open surgery, a vaginal hysterectomy, laparoscopic keyhole surgery, or advanced robotic-assisted hysterectomy, which is a console-guided, minimally invasive technique in which the surgeon operates through tiny incisions using a computer-assisted platform with magnified three-dimensional vision and finely controlled instruments, which can even perform lymph node dissection. The choice depends on the patient and the stage of the disease, but the less invasive routes, generally mean smaller wounds and a gentler recovery.
The message for women is simple. Menopause may close one chapter, but it does not mean that bleeding can be ignored. Any bleeding after periods that have stopped for a year calls for a visit to a gynaecologist without delay. If caught early, through a simple scan and a quick biopsy, the cause can be found and treated effectively.
(The author is a senior consultant, obstetrics & gynaecology, KIMSHEALTH, Thiruvananthapuram)
The opinions expressed in this article are those of the author and do not purport to reflect the opinions or views of THE WEEK.